124 related articles for article (PubMed ID: 3865480)
1. Implications of basic pharmacology in the therapy with esters of nandrolone.
van der Vies J
Acta Endocrinol Suppl (Copenh); 1985; 271():38-44. PubMed ID: 3865480
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic parameters of nandrolone (19-nortestosterone) after intramuscular administration of nandrolone decanoate (Deca-Durabolin) to healthy volunteers.
Wijnand HP; Bosch AM; Donker CW
Acta Endocrinol Suppl (Copenh); 1985; 271():19-30. PubMed ID: 3865478
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of nandrolone esters in oil vehicle: effects of ester, injection site and injection volume.
Minto CF; Howe C; Wishart S; Conway AJ; Handelsman DJ
J Pharmacol Exp Ther; 1997 Apr; 281(1):93-102. PubMed ID: 9103484
[TBL] [Abstract][Full Text] [Related]
4. Anabolic androgenic steroid nandrolone decanoate reduces hypothalamic proopiomelanocortin mRNA levels.
Lindblom J; Kindlundh AM; Nyberg F; Bergström L; Wikberg JE
Brain Res; 2003 Oct; 986(1-2):139-47. PubMed ID: 12965238
[TBL] [Abstract][Full Text] [Related]
5. The effects of nandrolone, testosterone and their decanoate esters on murine lupus.
Verheul HA; Stimson WH; den Hollander FC; Schuurs AH
Clin Exp Immunol; 1981 Apr; 44(1):11-7. PubMed ID: 6973425
[TBL] [Abstract][Full Text] [Related]
6. The androgenic anabolic steroid nandrolone decanoate prevents osteopenia and inhibits bone turnover in ovariectomized cynomolgus monkeys.
Jerome CP; Power RA; Obasanjo IO; Register TC; Guidry M; Carlson CS; Weaver DS
Bone; 1997 Apr; 20(4):355-64. PubMed ID: 9108356
[TBL] [Abstract][Full Text] [Related]
7. Anabolic and androgenic activities, in rat, of some nandrolone and androstanolone esters.
Chaudry MA; James KC; Ng CT; Nicholls PJ
J Pharm Pharmacol; 1976 Dec; 28(12):882-5. PubMed ID: 12263
[TBL] [Abstract][Full Text] [Related]
8. The effects of nandrolone decanoate on cocaine-induced kindling in male rats.
Long SF; Wilson MC; Davis WM
Neuropharmacology; 2000 Sep; 39(12):2442-7. PubMed ID: 10974328
[TBL] [Abstract][Full Text] [Related]
9. Nandrolone decanoate enhances hypothalamic biogenic amines in rats.
Tamaki T; Shiraishi T; Takeda H; Matsumiya T; Roy RR; Edgerton VR
Med Sci Sports Exerc; 2003 Jan; 35(1):32-8. PubMed ID: 12544632
[TBL] [Abstract][Full Text] [Related]
10. Nandrolone decanoate reduces changes induced by hindlimb suspension in voltage-dependent tension of rat soleus muscle.
Bouhlel A; Joumaa WH; Léoty C
Jpn J Physiol; 2003 Apr; 53(2):77-87. PubMed ID: 12877764
[TBL] [Abstract][Full Text] [Related]
11. Chronic administration of nandrolone decanoate does not increase the plasma homocysteine level of male rats.
Mirkhani H; Golbahar J; Shokri S
Basic Clin Pharmacol Toxicol; 2005 Oct; 97(4):214-7. PubMed ID: 16176555
[TBL] [Abstract][Full Text] [Related]
12. Effects of nandrolone decanoate therapy on bone mass and calcium metabolism in women with established post-menopausal osteoporosis: a double-blind placebo-controlled study.
Gennari C; AgnusDei D; Gonnelli S; Nardi P
Maturitas; 1989 Sep; 11(3):187-97. PubMed ID: 2687645
[TBL] [Abstract][Full Text] [Related]
13. Cross-over study of fat-corrected forearm mineral content during nandrolone decanoate therapy for osteoporosis.
Need AG; Horowitz M; Walker CJ; Chatterton BE; Chapman IC; Nordin BE
Bone; 1989; 10(1):3-6. PubMed ID: 2736154
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of 17 alpha-methyltestosterone, methandrostenolone, and nandrolone decanoate on the sexual behavior of castrated male rats.
Clark AS; Fast AS
Behav Neurosci; 1996 Dec; 110(6):1478-86. PubMed ID: 8986348
[TBL] [Abstract][Full Text] [Related]
15. Nandrolone decanoate treatment affects sarcoplasmic reticulum Ca(2+) ATPase function in skinned rat slow- and fast-twitch fibres.
Bouhlel A; Joumaa WH; Léoty C
Pflugers Arch; 2003 Sep; 446(6):728-34. PubMed ID: 12811564
[TBL] [Abstract][Full Text] [Related]
16. Characterization of bone mineral composition in the proximal tibia of cynomolgus monkeys: effect of ovariectomy and nandrolone decanoate treatment.
Huang RY; Miller LM; Carlson CS; Chance MR
Bone; 2002 Mar; 30(3):492-7. PubMed ID: 11882463
[TBL] [Abstract][Full Text] [Related]
17. Treatment of postmenopausal osteoporosis: is the anabolic steroid nandrolone decanoate a candidate?
Johansen JS; Hassager C; Pødenphant J; Riis BJ; Hartwell D; Thomsen K; Christiansen C
Bone Miner; 1989 Apr; 6(1):77-86. PubMed ID: 2665884
[TBL] [Abstract][Full Text] [Related]
18. Use of biological model of isolated overloading of skeletal muscle for determination of anabolic effect of steranobols.
Ivanenko TI; Fedotov VP; Almaeva SN; Belen'kii EE
Neurosci Behav Physiol; 1980; 10(3):223-7. PubMed ID: 7413077
[No Abstract] [Full Text] [Related]
19. The effects of 17 alpha-methyltestosterone, methandrostenolone, and nandrolone decanoate on the rat estrous cycle.
Blasberg ME; Langan CJ; Clark AS
Physiol Behav; 1997 Feb; 61(2):265-72. PubMed ID: 9035257
[TBL] [Abstract][Full Text] [Related]
20. Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer.
Chlebowski RT; Herrold J; Ali I; Oktay E; Chlebowski JS; Ponce AT; Heber D; Block JB
Cancer; 1986 Jul; 58(1):183-6. PubMed ID: 3518910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
